| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2021 | Aug 30, 2021 | Prelude Therapeutics Inc | Chief Scientific Officer | Sell | 42.5 | -7,714 | -1.10% | ✓ | $275.8K |
| Aug 13, 2021 | Aug 17, 2021 | Prelude Therapeutics Inc | Chief Scientific Officer | Sell | 45.0 | -2,286 | -1.30% | ✓ | $80.2K |
| Jul 27, 2021 | Jul 29, 2021 | Prelude Therapeutics Inc | Chief Scientific Officer | Sell | 22.5 | -20,000 | -10.37% | ✓ | $709.4K |
| May 7, 2021 | May 11, 2021 | Prelude Therapeutics Inc | Chief Scientific Officer | Sell | 30.0 | -10,000 | -5.47% | ✓ | $408.2K |
| Apr 8, 2021 | Apr 15, 2021 | Prelude Therapeutics Inc | Chief Scientific Officer | Sell | 53.8 | - | 0.00% | ✓ | $177.5K |
| Apr 7, 2021 | Apr 9, 2021 | Prelude Therapeutics Inc | Chief Scientific Officer | Sell | 51.3 | - | 0.00% | ✓ | $604.1K |